Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Who Will Emerge As Best In Class Of The FGF21 Analogs In NASH?
Nov 29 2023
•
By
Joseph Haas
Three firms developing FGF21 analogs for NASH made their cases at AASLD • Source: Scrip
More from Strategy
More from Business